By developing this in-depth understanding of the impacts of the GLP-1s on patient populations, treatment paradigms and clinician messaging, MedTech companies will be able to make informed strategic decisions to stay the course or pivot to other promising segments if needed
I think it emphasizes the importance of [matching] treatment to the right patient and making sure that we, as clinicians, really counsel patients about what to expect and how to reduce their risk of having those side effects. Both pills target GLP-1 receptors in the body to increase insulin secretion and satiety levels
Most of the semaglutide in your body clears in about five weeks, but it can take up to seven weeks in some people after the last dose
Both are compounded medications, not the branded products, and your provider determines which medication and formulation is right for you in line with current FDA regulations
doi: 10.1159/000510255
This studys strength lies in its prospective design and objective gastric ultrasound assessment, reducing potential bias inherent in retrospective reviews [34]